Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of multidrug-resistant viruses in the immunocompromised host.

Literature DB >> 22188225

Management of multidrug-resistant viruses in the immunocompromised host.

Abstract

Multidrug-resistant viruses remain a clinically challenging complication in the immunocompromised host. This review discusses mechanisms of viral resistance and treatment options in this context with particular emphasis on the immunocompromised haematology patient. We also outline some of the newer agents and treatment strategies being developed to treat multidrug-resistant viruses.

Entities: Species

Mesh：

Substances：
Antiviral Agents

Year: 2011 PMID： 22188225 DOI： 10.1111/j.1365-2141.2011.08988.x

Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998

Keyword Cloud
Cited

9 in total

1. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.

Authors: Michael D Keller; Sam Darko; Haili Lang; Amy Ransier; Christopher A Lazarski; Yunfei Wang; Patrick J Hanley; Blachy J Davila; Jennifer R Heimall; Richard F Ambinder; A John Barrett; Cliona M Rooney; Helen E Heslop; Daniel C Douek; Catherine M Bollard
Journal: Br J Haematol Date: 2019-06-20 Impact factor: 6.998

2. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.

Authors: Maimoona S Bhutta; Daniel G Sausen; Kirstin M Reed; Elisa S Gallo; Pamela S Hair; Brittany P Lassiter; Neel K Krishna; Kenji M Cunnion; Ronen Borenstein
Journal: Viruses Date: 2021-07-22 Impact factor: 5.818

3. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Authors: Makoto Yamamoto; Hiroshi Onogi; Isao Kii; Suguru Yoshida; Kei Iida; Hiroyuki Sakai; Minako Abe; Toshiaki Tsubota; Nobutoshi Ito; Takamitsu Hosoya; Masatoshi Hagiwara
Journal: J Clin Invest Date: 2014-07-08 Impact factor: 14.808

4. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes.

Authors: Swati Naik; Sarah K Nicholas; Caridad A Martinez; Ann M Leen; Patrick J Hanley; Steven M Gottschalk; Cliona M Rooney; I Celine Hanson; Robert A Krance; Elizabeth J Shpall; Conrad R Cruz; Persis Amrolia; Giovanna Lucchini; Nancy Bunin; Jennifer Heimall; Orly R Klein; Andrew R Gennery; Mary A Slatter; Mark A Vickers; Jordan S Orange; Helen E Heslop; Catherine M Bollard; Michael D Keller
Journal: J Allergy Clin Immunol Date: 2016-02-24 Impact factor: 10.793

Management of multidrug-resistant viruses in the immunocompromised host.

1. T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.

2. Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.

3. CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

4. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes.

Review 5. Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders.

Review 6. KSHV targeted therapy: an update on inhibitors of viral lytic replication.

7. Formulation and Evaluation of Antibacterial Creams and Gels Containing Metal Ions for Topical Application.

8. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.

Review 9. Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.